
Arkéa invests €2m in Lyamtech
Arkéa Capital Investissement has invested €2m in orthopaedic footwear company Lyamtech.
The investment will be used to grow the company through acquisitions as the orthopaedic footwear market is highly fragmented.
Company
Based in Niort, France, Lyamtech designs made-to-measure orthopaedic footwear. The company was founded in 1980. Lyamtech recorded consolidated sales of €5m over the past 12 months.
People
Marc Brière is CEO of Arkéa.
Advisers
Equity – Cabinet LB, Youna Lebour Feillard (Legal); Becuoze, Loic Saint Gearges, Charles-André Lefeuvre (Financial due diligence).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater